文献速递产科母胎医学

美国孕前糖尿病孕妇分娩住院期间糖尿病酮症酸中毒及不良结局,2010-2020年

Diabetic Ketoacidosis and Adverse Outcomes Among Pregnant Individuals With Pregestational Diabetes in the United States, 2010-2020.
PubMed 文献 · Obstet Gynecol · 2024-07-11

该研究利用美国全国再入院数据库2010-2020年数据,分析孕前糖尿病孕妇分娩住院期间糖尿病酮症酸中毒(DKA)的频率、危险因素及不良结局。392,796例分娩中DKA发生率为1.2%(1型糖尿病4.0%,2型糖尿病0.2%),年均百分比变化为10.8%。DKA与严重孕产妇发病率、早产及妊娠期高血压疾病风险升高相关。

要点

  • 分娩住院DKA发生率1.2%,1型糖尿病4.0%高于2型糖尿病0.2%,年均百分比变化10.8%。
  • DKA与输血外严重孕产妇发病率(aOR 8.18)、重症监护操作(aOR 15.83)等风险升高相关。
  • DKA与早产(aOR 2.41)及妊娠期高血压疾病(aOR 1.11)风险升高相关。

核心结论

  • 2010至2020年间,美国孕前糖尿病孕妇分娩住院及产前住院DKA频率均上升。
  • DKA与孕产妇发病率及不良妊娠结局风险升高相关。
  • 分娩期DKA的危险因素与产前及产后DKA相似。

研究设计与样本

  • 采用美国医疗保健研究与质量局医疗成本与利用项目全国再入院数据库2010至2020年数据进行系列横断面研究。
  • 研究对象为孕前糖尿病(1型和2型糖尿病)分娩住院孕妇,共392,796例分娩,其中1型糖尿病27.2%、2型糖尿病72.8%。

主要发现

  • 分娩住院DKA共4,778例(1型糖尿病89.1%,2型糖尿病10.9%),总频率1.2%(1型糖尿病4.0%,2型糖尿病0.2%),年均百分比变化10.8%(95%CI 8.2-13.2%)。
  • 分娩住院DKA与输血外严重孕产妇发病率(20.8% vs 2.4%,aOR 8.18,95%CI 7.20-9.29)、重症监护操作(7.3% vs 0.4%,aOR 15.83,95%CI 12.59-19.90)、心脏并发症(7.8% vs 0.8%,aOR 8.87,95%CI 7.32-10.76)、急性肾衰竭(12.3% vs 0.7%,aOR 9.78,95%CI 8.16-11.72)及输血(6.2% vs 2.2%,aOR 2.27,95%CI 1.87-2.75)风险升高相关。
  • 分娩住院DKA与早产(31.9% vs 13.5%,aOR 2.41,95%CI 2.17-2.69)及妊娠期高血压疾病(37.4% vs 28.1%,aOR 1.11,95%CI 1.00-1.23)风险升高相关。
  • 产前DKA总体频率3.1%,年均百分比变化4.1%(95%CI 0.3-8.6%);产后DKA总体频率0.4%,年均百分比变化3.5%(95%CI -1.6%至9.6%)。
  • 3,092例产前DKA住院中15.7%(n=485)在分娩住院时复发DKA;1,419例产后DKA住院中20.0%(n=285)此前分娩住院时曾有DKA。

关键数值与推荐

  • 分娩住院DKA的危险因素包括1型糖尿病(较2型糖尿病)、较年轻年龄、较大都市医院分娩、医疗补助保险、较低收入、多胎妊娠及既往精神疾病。
  • 上述分娩住院DKA危险因素与产前及产后住院DKA相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the frequency of, risk factors for, and adverse outcomes associated with diabetic ketoacidosis (DKA) at delivery hospitalization among individuals with pregestational diabetes (type 1 and 2 diabetes mellitus) and secondarily to evaluate the frequency of and risk factors for antepartum and postpartum hospitalizations for DKA. METHODS: We conducted a serial, cross-sectional study using the Agency for Healthcare Research and Quality's Healthcare Cost and Utilization Project Nationwide Readmissions Database from 2010 to 2020 of pregnant individuals with pregestational diabetes hospitalized for delivery. The exposures were 1) sociodemographic and clinical risk factors for DKA and 2) DKA. The outcomes were DKA at delivery hospitalization, maternal morbidity (nontransfusion severe maternal morbidity (SMM), critical care procedures, cardiac complications, acute renal failure, and transfusion), and adverse pregnancy outcomes (preterm birth, hypertensive disorders of pregnancy, and cesarean delivery) and secondarily DKA at antepartum and postpartum hospitalizations. RESULTS: Of 392,796 deliveries in individuals with pregestational diabetes (27.2% type 1 diabetes, 72.8% type 2 diabetes), there were 4,778 cases of DKA at delivery hospitalization (89.1% type 1 diabetes, 10.9% type 2 diabetes). The frequency of DKA at delivery hospitalization was 1.2% (4.0% with type 1 diabetes, 0.2% with type 2 diabetes), and the mean annual percentage change was 10.8% (95% CI, 8.2-13.2%). Diabetic ketoacidosis at delivery hospitalization was significantly more likely among those who had type 1 diabetes compared with those with type 2 diabetes, who were younger in age, who delivered at larger and metropolitan hospitals, and who had Medicaid insurance, lower income, multiple gestations, and prior psychiatric illness. Diabetic ketoacidosis during the delivery hospitalization was associated with an increased risk of nontransfusion SMM (20.8% vs 2.4%, adjusted odds ratio [aOR] 8.18, 95% CI, 7.20-9.29), critical care procedures (7.3% vs 0.4%, aOR 15.83, 95% CI, 12.59-19.90), cardiac complications (7.8% vs 0.8%, aOR 8.87, 95% CI, 7.32-10.76), acute renal failure (12.3% vs 0.7%, aOR 9.78, 95% CI, 8.16-11.72), and transfusion (6.2% vs 2.2%, aOR 2.27, 95% CI, 1.87-2.75), as well as preterm birth (31.9% vs 13.5%, aOR 2.41, 95% CI, 2.17-2.69) and hypertensive disorders of pregnancy (37.4% vs 28.1%, aOR 1.11, 95% CI, 1.00-1.23). In secondary analyses, the overall frequency of antepartum DKA was 3.1%, and the mean annual percentage change was 4.1% (95% CI, 0.3-8.6%); the overall frequency of postpartum DKA was 0.4%, and the mean annual percentage change was 3.5% (95% CI, -1.6% to 9.6%). Of 3,092 antepartum hospitalizations among individuals with DKA, 15.7% (n=485) had a recurrent case of DKA at delivery hospitalization. Of 1,419 postpartum hospitalizations among individuals with DKA, 20.0% (n=285) previously had DKA at delivery hospitalization. The above risk factors for DKA at delivery hospitalization were similar for DKA at antepartum and postpartum hospitalizations. CONCLUSION: The frequency of DKA at delivery hospitalization and antepartum hospitalizations for DKA increased between 2010 and 2020 among deliveries in individuals with pregestational diabetes in the United States. Diabetic ketoacidosis is associated with an increased risk of maternal morbidity and adverse pregnancy outcomes. Risk factors for DKA at delivery were similar to those for DKA during the antepartum and postpartum periods.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Wen T, Friedman AM, Gyamfi-Bannerman C, et al. Diabetic Ketoacidosis and Adverse Outcomes Among Pregnant Individuals With Pregestational Diabetes in the United States, 2010-2020. Obstet Gynecol. 2024. PMID: 38991217. doi:10.1097/AOG.0000000000005667

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。